medigraphic.com
ISSN 2078-7162 (Print)

2019, Number 3

<< Back Next >>

Rev Cub de Med Fis y Rehab 2019; 11 (3)

Pulsed electromagnetic fields in the treatment of prostatic hyperplasia

Borroto RV, Aguilera MY, Cortez SR, Jiménez TA

Language: Spanish
References: 34
Page: 1-18
PDF size: 555.17 Kb.


ABSTRACT

Introduction: Benign prostatic hyperplasia is one of the most common diseases in humans and is a major health problem with very high economic costs.
Objective: To evaluate the effect of treatment with pulsed electromagnetic fields on moderate benign prostatic hyperplasia according to the international scale of prostatic symptoms.
Methods: A randomized, prospective, longitudinal study was conducted in 120 patients with clinical and radiological diagnosis of benign prostatic hyperplasia and moderate symptoms. They attended the natural and traditional medicine practice of the Institute of Neurology and Neurosurgery between September 2016 and February 2017. The sample was divided into two groups of 60 patients. The members of group 1 or control did not receive specific treatment but expectant behaviour with hygienic-dietary indications. The members of the second group were given 30 sessions of pulsed electromagnetic fields before and after three months of treatment. In both groups, the international scale of prostate symptoms, the IIEF-5 erectile dysfunction questionnaire, specific prostate antigen and the degree of prostatic hypertrophy according to the volume calculated by abdominal ultrasound were applied.
Results: The group treated with pulsed electromagnetic fields was statistically (p = 0.00) superior in all measured parameters with respect to the group that received expectant behavior. No adverse events were reported.
Conclusions: Therapy with pulsed electromagnetic fields is safe and effective in benign prostatic hyperplasia with moderate symptoms according to the international scale of prostatic symptoms.


REFERENCES

  1. Wilt TJ, N’Dow J. Benign prostatic hyperplasia. Part 1-Diagnosis. BMJ. 2008 [acceso: 13/01/2012]; 336:146-9. Disponible en: http://www.bmj.com/content/336/7636/146

  2. Casajuana Brunet J, Aragonés Fornés R. Hiperplasia benigna de próstata. Guías Clínicas Fisterra. 2010 [acceso: 13/01/2012]. Disponible en: http://www.fisterra.com/guias-clinicas/hiperplasia-benigna-prostata/

  3. Edwards J. Diagnosis and management of benign prostatic hyperplasia. -Am Fam Physician - 15-MAY-2008; 77(10):1403-10.

  4. Seisen T, Drouin SJ, Rouprèt M. Hiperplasia benigna de próstata. EMC-tratados de medicina. 2017; 21(2):1-10.

  5. Brenes F, Castiñeiras J, Cozar JM, Fernández Pro A, Martín JA, Molero JM, et al. Criterios de derivación en HBP para AP. Documento de consenso 2011. Sociedad Española de Medicina de Familia y Comunitaria (semFYC). Sociedad Española de Médicos de Atención Primaria (SEMERGEN). Sociedad Española de Médicos Generales y de Familia (SEMG). Asociación Española de Urología (AEU). Disponible en: http://www.semergen.es/semergen/content-Files/13200/es/HBP.pdf

  6. Kaplan SA. Benign prostatic hyperplasia and prostatis. In: Goldman L, Schafer AI, eds. Goldman-Cecil Medicine. 25th ed. Philadelphia, PA: Elsevier Saunders; 2016: chap 129.

  7. Hunter KF, Glazener CMA, Moore KN. Tratamiento conservador para la incontinencia urinaria posterior a la prostatectomía (Cochrane Review). In: La biblioteca Cochrane Plus, Issue 3, 2007. Oxford: Update Software.

  8. Martín Cordero JE, García Delgado JA. Introducción a la magnetoterapia. Editorial CIMEQ. Primera edición 2002. Ciudad Habana, Cuba.

  9. Borroto V. Campos electromagnéticos pulsados y ozono en el tratamiento de la artrosis de rodilla en el adulto mayor. Revista Española de Ozonoterapia. 2016 (6)1:27-39.

  10. Túnez I, Drucker Colín R, Jimena I, Medina F, Muños M, Peña J, et al. Transcranial magnetic stimulation attenuates cell loss and oxidative damage in the striatum induced in the 3-nitropropionic model of Huntington’s disease. J Neurochem. 2006; 97:619–30.

  11. Anninos P, Papadopoulos I, Kotini A, Adamopoulos A. Differential diagnosis of prostate lesions with the use of biomagnetic measurements and non-linear analysis. Urol Res. 2003; 31:32–6.

  12. Vianale G, Reale M, Amerio P, Stefanachi M, Di Luzio S, Muraro R. Extremely low frequency electromagnetic field enhances human keratinocyte cell growth and decreases proinflammatory chemokine production. Br J Dermatol. 2008; 158:1189-96.

  13. Johnson MT, Waite LR, Nindl G. Noninvasive treatment of inflammation using electromagnetic fields: current and emerging therapeutic potential. Biomed Sci Instrum. 2004; 40: 469-74.

  14. Leoci R, Aiudi G, Silvestre F, Lissner E, Lacalandra GM. Pulsed Electromagnetic Field on Canine BPH. The Prostate. 2014; 74:1132-41.

  15. Hany M Elgohary, Sayed AT. Pulsed electromagnetic field with or without exercise therapy in the treatment of benign prostatic hyperplasia. J Phys Ther Sci. 2017; 29:1305-10.

  16. Kirby M, Chapple C, Jackson G, Eardley I, Edwards D, Hackett G, et al. Erectile dysfunction and lower urinary tract symptoms: a consensus on the importance of co-diagnosis. Int J Clin Pract. 2013 Julio; 67(7):606-18.

  17. The management of lower urinary tract symptoms in men. NICE clinical guideline 97(2010). Disponible en: http://www.nice.org.uk/nicemedia/live/12984/48557/48557.pdf

  18. Ghafar MA, Puchner PJ, Anastasiadis AG, Cabelin MA, Buttyan R. ¿El sistema vascular prostática contribuir al desarrollo de la hiperplasia benigna de próstata? Curr Urol Rep. 2002; 3:292-96.

  19. Lowe Franklin C. Metas para el tratamiento de hiperplasia prostática benigna. Urology 2002; 59:1-2.

  20. Chughtai B, Lee R, Te A, S Kaplan. Papel de la inflamación en la hiperplasia benigna de próstata. Rev Urol. 2011; 13:147-50.

  21. Brenes Bermúdez FJ, Brotons Muntó F, Castiñeiras Fernández J. Documento de consenso sobre pautas de actuación y seguimiento del varón con síntomas del tracto urinario inferior secundarios a hiperplasia prostática benigna. Semergen. 2016; 42(8):547-56.

  22. Rubik B, Becker RO, Flower RG, Hazlewood CF, Liboff AR, Walleczek J. Aplicaciones del bioelectromagnetismo en medicina. Panel de estudio de los Institutos Nacionales de Salud (NIH). Disponible en: www.sld.cu/galerias/pdf/sitios/rehabilitacion-fis/biomagnetismo.pdf

  23. Appelt C. Pulsed Electromagnetic Field Therapy (PEMF). New Perspectives in Therapy. Anti-Aging Medical News. 2006:2-4.

  24. Neimark AI, Snegirev IV, Neimark BA. Transrectal magnetoterapia de la próstata desde el dispositivo Intramag en la profilaxis de las complicaciones postoperatorias de la resección transuretral de adenoma de próstata. Urología. 2006; 75:77-9.

  25. Corona G, Gacci M, Maseroli E, Rastrelli G, Vignozzi L, Sforza A, et al. Clinical correlates of enlarged prostate size in subjects with sexual dysfunction. Asian J Androl. 2014; 16:767-73.

  26. Wespes E, Amar E, Eardley I, Giuliano F, Hatzichristou D, Hatzimouratidis K, et al. Guía clínica sobre la disfunción sexual masculina: disfunción eréctil y eyaculación precoz. European Association of Urology; 2010.

  27. Hany ME. Pulsed electromagnetic field with or without exercise therapy in the treatment of benign prostatic hyperplasia Ther. J. Phys. Sci. 2017; 29(8):1310.

  28. Carvajal García R. Relación entre el antígeno prostático específico y la hiperplasia prostática. Rev Mex Urol. 2014; 74(6):342-5.

  29. McFarlane JP, Foley SJ, de Winter P. Acute suppression of idiopathic detrusor instability with magnetic stimulation of the sacral nerve roots. Br J Urol. 1997; 80:734-41.

  30. Salvatore JR, Weitberg AB, Mehta S. Nonionizing electromagnetic fields and cancer: a review. Oncology (Williston Park). 1996; 10: 563-570, 573-4, 577-8.

  31. Binhi V, Savin A: Effects of weak magnetic fields on biological systems: physical aspects. Phys Uspekhi. 2003; 46:259-91.

  32. Kawczyk Krupka A, Sieron A, Shani J, Czuba ZP, Krol W. Biological effects of extremely low-frequency magnetic fields on stumlated macrophages J774-2 in cell culture. Electromagn Biol Med. 2002; 21:141-53.

  33. Giannakopoulos XK, Giotis C, Karkabounas SCH, Verginadis II, Simos YV, Peschos D, et al. Los efectos de los campos electromagnéticos pulsados en la hiperplasia benigna de próstata. Int Urol Nephrol. 2011 Dec; 43 (4):955-60.

  34. Haddad JB, Obolensky AG, Shinnick P. The biologic effects and the therapeutic mechanism of action of electric and electromagnetic field stimulation on bone and cartilage: new findings and a review of earlier work. J Altern Complement Med. 2007; 13:485-90.




2020     |     www.medigraphic.com